Yield10 Bioscience

Yield10 Bioscience

Signal active

Investment Firm

Overview

Yield10 Bioscience is a biotechnology company that specializes in developing innovative crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques. The company focuses on creating proprietary traits and technologies that can enhance the productivity and nutritional profile of various crops, with an emphasis on oilseed crops and other specialty crops. Yield10 Bioscience employs cutting-edge biotechnological tools to develop and test their plant traits and technologies. This includes utilizing techniques like gene editing, genome engineering, and metabolic engineering to introduce specific genetic modifications into plants that can lead to desired traits.

Highlights

Founded

1992

Industry

Biotechnology

Employees

11-50

Investment

1

Lead Investment

1

Exits

1

Stages

Early Stage Venture

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

Yield10 Bioscience, established in 1992 and headquartered in United States, North America., specializes in Early Stage Venture investments across Biotechnology, Health Care, Medical Device. The organization boasts a portfolio of 1 investments, with an average round size of $4.4M and 1 successful exits. Their recent investments include Tepha. The highest investment round they participated in was $53.0M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Robert L. Van Nostrand

Robert L. Van Nostrand

Board of Directors

imagePlace Oliver P. Peoples

Oliver P. Peoples

President and CEO

imagePlace Lynne Brum

Lynne Brum

VP of Planning and Corporate Communications

imagePlace Sarah P. Cecil

Sarah P. Cecil

General Counsel

Investment portfolio

Yield10 Bioscience has made 1 investments. Their most recent investment was on Mar 11, 2003, when Tepha raised $4.4M.

investments

1

Diversity investments

0

Lead investments

1

Number of exits

1

Investments

1

Annouced DateOrganization NameIndustryMoney Raised
Mar 11, 2003
Tepha Tepha
Biotechnology4.4M

Exits

1

Funding Timeline

Funding rounds

1

Investors

5

Funds

0

Funding Rounds

1

Yield10 Bioscience has raised 1 rounds. Their latest funding was raised on Mar 11, 2003 from a Series A - Tepha round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Mar 11, 2003
Series A - Tepha Series A - Tepha
-4.4M-

Investors

9

Yield10 Bioscience is funded by 9 investor(s). Jack W. Schuler Living Trust and Oracle Investment Management Inc. Kantor are the most recent investors.

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.